Semaglutide Weight Loss in Doral, FL

Semaglutide is a prescription GLP-1 receptor agonist used, alongside diet and exercise, to support weight management and blood-sugar regulation in eligible adults. Through DripVitals, patients in Doral and across Miami-Dade are evaluated online and, if appropriate, prescribed semaglutide that ships from a licensed pharmacy.

What semaglutide is

Semaglutide mimics GLP-1, a hormone that signals fullness, slows how quickly the stomach empties, and helps regulate blood sugar. It is the active ingredient in the FDA-approved medicines Wegovy and Ozempic. In large randomized trials of FDA-approved branded semaglutide, treatment alongside lifestyle changes produced meaningful average weight loss (Wilding et al., 2021).

Branded vs. compounded semaglutide

FDA-approved branded semaglutide (Wegovy, Ozempic) has been reviewed by the FDA for safety and effectiveness. Compounded semaglutide is prepared by a licensed pharmacy to fill an individual prescription; it is not FDA-approved, and compounded preparations are not the same as — and should not be assumed equivalent to — the approved products. The trial results above were obtained with branded semaglutide, not compounded preparations. Your clinician explains which option, if any, is appropriate for you.

Why a clinician consultation matters

Semaglutide is available only by prescription. A licensed clinician reviews your medical history, current medications, and goals to decide whether treatment is appropriate and safe, and not everyone qualifies. You can start the online consultation here.

Like any medication, semaglutide carries risks and is not appropriate for everyone. Reviewing the following with a licensed clinician is an essential part of treatment, and the FDA-approved labeling should be read in full.

Boxed warning: thyroid C-cell tumors

FDA-approved semaglutide carries a boxed warning about the risk of thyroid C-cell tumors observed in rodents. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician about any such history.

Common and serious side effects

Common effects can include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose increases. Serious risks reported with GLP-1 therapy include pancreatitis, gallbladder problems, low blood sugar (particularly alongside other diabetes medicines), kidney issues from dehydration, and allergic reactions. Seek prompt medical care for severe or persistent symptoms.

Who should not use it

Semaglutide is generally not used during pregnancy or breastfeeding, in people with the thyroid or MEN 2 history above, with a history of pancreatitis, or with certain other conditions. Your clinician reviews your history and will decline treatment when it is not safe or appropriate. Not everyone who applies will qualify.

Drug interactions and follow-up

Share a complete list of your prescriptions, over-the-counter products, vitamins, and supplements so your clinician can check for interactions and adjust care as needed. Report side effects and health changes during follow-up. Individual results vary, and no specific outcome is guaranteed.

Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. A licensed provider determines whether a compounded medication is appropriate based on an individual patient’s medical needs.

Semaglutide is one of several GLP-1 options. Tirzepatide (the active ingredient in Mounjaro and Zepbound) acts on two gut-hormone receptors (GIP and GLP-1) rather than one, and some people are prescribed oral rather than injectable formulations. Each option differs in dosing, evidence, and suitability.

Which option, if any, is right for you depends on your goals, medical history, and a licensed clinician’s assessment. You can compare our GLP-1 weight-loss treatments and review the options together during your visit.

A DripVitals semaglutide program is a clinician-guided subscription that bundles your care and medication into one plan — convenient for Doral’s between-meetings schedule. Depending on what your clinician prescribes, it typically includes:

• Online medical consultation and licensed-clinician review
• Your prescribed medication from a licensed pharmacy (branded or compounded, as appropriate)
• Injection supplies (syringes and alcohol pads), where applicable
• Free, discreet shipping to Doral and across Florida
• Ongoing messaging access to your care team
• Follow-up check-ins with dose titration when clinically appropriate
• A subscription you can cancel at any time

Semaglutide Cost and Pricing in Doral

Pricing depends on the plan you choose and what your clinician prescribes; branded and compounded options differ in price. There are no hidden fees, and you see exact pricing before you confirm.

*The $199/month rate reflects a 6-month commitment paid upfront or through a buy-now-pay-later program. Actual price depends on the plan and medication prescribed, including whether a branded or compounded option is used. Plans are offered as a subscription that can be canceled at any time.

These sources report trials conducted with FDA-approved branded semaglutide. They describe general research findings and do not establish outcomes for compounded preparations or guarantee individual results from this program.

• Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)Wilding JPH, et al; STEP 1 Study Group. N Engl J Med. 2021;384(11):989–1002. Trial of FDA-approved branded semaglutide 2.4 mg.
• Continued Semaglutide vs Placebo on Weight-Loss Maintenance (STEP 4)Rubino D, et al; STEP 4 Investigators. JAMA. 2021;325(14):1414–1425. Conducted with FDA-approved branded semaglutide.
• Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT)Lincoff AM, et al. N Engl J Med. 2023;389(24):2221–2232. Conducted with FDA-approved branded semaglutide.